Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Certican versus calcineurin inhibitor maintenance regimen in heart transplant recipients with CNI-related renal insufficiency
2007-002102-22Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of everolimus in Renal Insufficiency (RI) and Cardiac Rejection (2 arms), sponsored by UZ Leuven. Primary endpoint: Change in renal function. Started Sep 2007; status: completed.
02
Drugs
everolimus
03
Conditions
Renal Insufficiency (RI)Cardiac Rejection
Beyond the preview
Go deeper on 2007-002102-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002102-22.